GENETIC SOLUTIONS FOR PROFESSIONALSAmplexa Genetics offers cutting-edge testing to help professionals diagnose and select appropriate treatment for their patients.
COVID-19 SOLUTIONSWhether it is yourself, your employees, or your customers, who need to be tested:
Amplexa Genetics has the solution.
FERTILITYAmplexa Genetics offers testing of fertilized eggs grown in connection with IVF treatments; testing of future parents for carrier status of rare hereditary diseases; compatibility tests (client-donor); and donor screening tests.
TECHNICAL SOLUTIONSWe offer a variety of comprehensive, technical sequencing solutions, that combine science and information technology with our highly adaptable bioinformatics service.
WE CAN HELP YOU IN YOUR FERTILITY JOURNEYWhen it comes to fertility issues, needs are different, and treatment will vary from person to person. Choose the Amplexa test you think corresponds to your situation. You can do this by reading the descriptions below.
SPERM DONOR SCREENING
EGG DONOR SCREENING
X-LINKED CARRIER TEST
Meet us in Copenhagen!Amplexa Genetics will be participating as an exhibitor at ESHRE 2023.
European Society of Human Reproduction and Embryology (ESHRE)'s Annual Meeting is an international event that brings together reproductive medicine and science experts national event that brings together experts from the reproductive medicine and science field. It serves as a platform for scientific sessions, knowledge exchange, and invaluable networking opportunities among peers.
As a leading player in the field, Amplexa Genetics is honored to be a part of this esteemed gathering. We look forward to contributing to the vibrant discussions, sharing our expertise, and forging collaborations with fellow professionals. Our participation underscores our commitment to advancing research and education in reproductive medicine and embryology.
This event serves as a hub for presenting and discussing the latest developments and advancements, pushing the boundaries of reproductive medicine and embryology.
Amplexa Genetics is excited to showcase our innovative solutions, cutting-edge technologies, and research contributions during the ESHRE 2023 conference.
Amplexa is Børsen Gazelle Regional Winner for Southern Denmark 2022!It’s now official, and we’re bursting with pride: Amplexa is Børsen Gazelle Regional Winner for Southern Denmark 2022!
We received the fantastic news on Thursday at the Regional Award Ceremony at Odense Odeon. We were dressed up in our best attire and had a blast of an evening, celebrating our new status with bubbles and tapas and selfies on the red carpet
PURPLE DAY, 26 MARCHToday, March 26th, is Purple Day, a day dedicated to raising epilepsy awareness worldwide. But at Amplexa, every day that we offer the best diagnosis in epilepsy is Purple Day.
Epilepsy is among the most common chronic neurological diseases, with a prevalence of around 1% in the general population.
RARE DISEASE DAYToday, on Rare Disease Day, we get together to raise awareness of the challenges involved in living with a rare disease.
At Amplexa we are passionate about raising community awareness through preventive actions. We make this possible with our gene panels: Genes2Life and Genes4Life.